Tenax regains compliance with Nasdaq minimum bid price rule

TENAX THERAPEUTICS, INC.

Nasdaq confirmed compliance on Jan 20, 2023 after stock closed at $1.00+ for ten consecutive trading days.
Previously notified of deficiency on Feb 17, 2022; extension granted through Feb 13, 2023.
Matter is now closed; no further action required to maintain listing under Bid Price Rule.

item 8.01

TENAX THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001654954-23-000627

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.